INTERNATIONAL PATENT: NEXTPOINT THERAPEUTICS, INC. FILES APPLICATION FOR "MULTISPECIFIC ANTIBODIES OR ANTIGEN BINDING FRAGMENTS THEREOF TO B7-H7 AND IMMUNE EFFECTOR CELL ANTIGENS"

GENEVA, Aug. 26 -- NEXTPOINT THERAPEUTICS, INC. (238 Main Street, 5th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/015857) for "MULTISPECIFIC ANTIBODIES OR ANTIGEN BINDING FRAGMENTS THEREOF TO B7-H7 AND IMMUNE EFFECTOR CELL ANTIGENS" on Feb 13, 2025. With publication no. WO/2025/175056, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ETEMAD-GILBERTSON, Bijan (c/o NextPoint Therapeutics, Inc.238 Main Street, 5th FloorCambridge, Massachusetts 02142), RAUSCH, Matthew (c/o NextPoint Therapeutics...